|
Q4 2017
Filed on Feb 14, 2018
|
292
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
26,500
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
100
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
4,726
|
$50.85 - $65.1
$240K - $308K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
533,563
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
227
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
19,376
|
$4.73 - $7.78
$91.6K - $151K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
37,634
|
N/A
|
|
Anthera Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
52,046
|
N/A
|
|
Ekso Bionics Holdings Inc
|
Q4 2017
Filed on Feb 14, 2018
|
702,364
|
N/A
|
|
Idera Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
416
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,322
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
237,322
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,375
|
N/A
|
|
Rexahn Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
169,901
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
66
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,000
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
275
|
N/A
|
|
Orexigen Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
19,700
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
542
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
466,880
|
N/A
|
|
Orexigen Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
197
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
341
|
N/A
|
|
Eyegate Pharmaceuticals Inc
|
Q4 2017
Filed on Feb 14, 2018
|
46,378
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
70,000
|
N/A
|
|
Stemline Therapeutics Inc
|
Q4 2017
Filed on Feb 14, 2018
|
43,749
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
224,810
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
28,517
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,689,778
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
75,000
|
$21.8 - $39.35
$1.64M - $2.95M
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
1,016
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
11,281
|
$17.39 - $31.12
$196K - $351K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
53,558
|
$8.19 - $11.19
$439K - $599K
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
152,127
|
N/A
|
|
|
Q4 2017
Filed on Feb 14, 2018
|
542
|
N/A
|
|